NDC to RxNorm Crosswalk 0009-7199 Somavert

View RxNorm Concepts, RxCUIs, Term Types

RxNorm Crosswalk Information

This drug is included in the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.

The RxNorm crosswalk for NDC code 0009-7199 indicates multiple RxNorm Concept Unique Identifiers known as RxCUIs associated to the product Somavert . The unique RxCUI concepts linked to this product are: 1549323, 1549452, 1549454, 1549456, 403806, 403807, 403808, 404457, 404458 and 404459. RxCUIs are identifiers that group each chemically distinct drug into a single code regardless of manufacturer or package size. Drugs mapped to the same RxCUI are considered the same drug as having the same ingredients, strengths, and dose forms. The RxNorm mapping may include repeated RxCUI concepts with different descriptions and term types.

RxCUI: 1549323

Concept: pegvisomant 25 MG Injection: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: pegvisomant 25 MG Injection: Term Type (TTY): SCD - Semantic Clinical Drug
Ingredient + Strength + Dose Form

RxCUI: 1549452

Concept: pegvisomant 30 MG Injection: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: pegvisomant 30 MG Injection: Term Type (TTY): SCD - Semantic Clinical Drug
Ingredient + Strength + Dose Form

RxCUI: 1549454

Concept: Somavert 30 MG Injection: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: pegvisomant 30 MG Injection [Somavert]: Term Type (TTY): SBD - Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name

Concept: Somavert 30 MG Injection: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 1549456

Concept: Somavert 25 MG Injection: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: pegvisomant 25 MG Injection [Somavert]: Term Type (TTY): SBD - Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name

Concept: Somavert 25 MG Injection: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 403806

Concept: pegvisomant 10 MG Injection: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: pegvisomant 10 MG Injection: Term Type (TTY): SCD - Semantic Clinical Drug
Ingredient + Strength + Dose Form

RxCUI: 403807

Concept: pegvisomant 15 MG Injection: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: pegvisomant 15 MG Injection: Term Type (TTY): SCD - Semantic Clinical Drug
Ingredient + Strength + Dose Form

RxCUI: 403808

Concept: pegvisomant 20 MG Injection: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: pegvisomant 20 MG Injection: Term Type (TTY): SCD - Semantic Clinical Drug
Ingredient + Strength + Dose Form

RxCUI: 404457

Concept: Somavert 10 MG Injection: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: pegvisomant 10 MG Injection [Somavert]: Term Type (TTY): SBD - Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name

Concept: Somavert 10 MG Injection: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 404458

Concept: Somavert 15 MG Injection: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: pegvisomant 15 MG Injection [Somavert]: Term Type (TTY): SBD - Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name

Concept: Somavert 15 MG Injection: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

RxCUI: 404459

Concept: Somavert 20 MG Injection: Term Type (TTY): PSN - Prescribable Name
Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.

Concept: pegvisomant 20 MG Injection [Somavert]: Term Type (TTY): SBD - Semantic Branded Drug
Ingredient + Strength + Dose Form + Brand Name

Concept: Somavert 20 MG Injection: Term Type (TTY): SY - Synonym
Synonym of another TTY, given for clarity.

What is RxNorm?

RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.

The goal of RxNorm is to facilitate the efficient exchange of drug information among the computer systems used by hospitals, pharmacies, clinics and other organizations. To achieve this goal RxNorm provides normalized names and unique identifiers for drugs and medicines.

What is an RXCUI?

An RxCUI is machine readable unique identifier that defines the same common concept. Every name and code provided to the National Library of Medicine receives an RXCUI. Drug products that map to the same RxCUI are considered the same drug while drugs that are distinct will have different RxCUIs.

What is a Term Type (TTY)?

Term Types (TTYs) are used to specify the level of complexity of each RxCUI term.

* This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.